These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 9189137

  • 21. Diffuse lung uptake of technetium-99m sulfur colloid in malaria.
    Leclerc Y, Verreault J, Bisson G.
    J Nucl Med; 1989 Jan; 30(1):117-9. PubMed ID: 2642952
    [Abstract] [Full Text] [Related]

  • 22. Is there a role for scintigraphic imaging of bone manifestations in Gaucher disease? A review of the literature.
    Mikosch P, Kohlfürst S, Gallowitsch HJ, Kresnik E, Lind P, Mehta AB, Hughes DA.
    Nuklearmedizin; 2008 Jan; 47(6):239-47. PubMed ID: 19057797
    [Abstract] [Full Text] [Related]

  • 23. Scintigraphic findings in progressive diaphyseal dysplasia.
    Lundy MM, Billingsley JL, Redwine MD, Turnbull GL, Brown TJ.
    J Nucl Med; 1982 Apr; 23(4):324-5. PubMed ID: 6461731
    [Abstract] [Full Text] [Related]

  • 24. Bone marrow extension and pelvic bone marrow activity in alcoholic liver disease. A RES scintigraphic investigation.
    Rudberg U.
    Acta Radiol; 1992 Sep; 33(5):464-7. PubMed ID: 1389658
    [Abstract] [Full Text] [Related]

  • 25. Improving bone marrow scintigraphy. A clinical and experimental study.
    Kalin B.
    Acta Radiol Suppl; 1993 Sep; 385():1-24. PubMed ID: 8517188
    [Abstract] [Full Text] [Related]

  • 26. [Gaucher disease: MR evaluation of bone marrow features during treatment with enzyme replacement].
    Poll LW, vom Dahl S, Koch JA, Börner D, Willers R, Cohnen M, Jung G, Scherer A, Niederau C, Häussinger D, Mödder U.
    Rofo; 2001 Oct; 173(10):931-7. PubMed ID: 11588682
    [Abstract] [Full Text] [Related]

  • 27. Velaglucerase alfa for the management of type 1 Gaucher disease.
    Morris JL.
    Clin Ther; 2012 Feb; 34(2):259-71. PubMed ID: 22264444
    [Abstract] [Full Text] [Related]

  • 28. Bone marrow uptake of 99mtechnetium-sulfur colloid after severe abdominal trauma in children.
    Smith FW, Brown RG, Gilday DL, Ash JM.
    Pediatr Radiol; 1981 Feb; 10(3):169-71. PubMed ID: 7220133
    [Abstract] [Full Text] [Related]

  • 29. Gaucher disease: assessment of skeletal involvement and therapeutic responses to enzyme replacement.
    Hermann G, Pastores GM, Abdelwahab IF, Lorberboym AM.
    Skeletal Radiol; 1997 Dec; 26(12):687-96. PubMed ID: 9453101
    [Abstract] [Full Text] [Related]

  • 30. Reticuloendothelial "activation" noted after splenectomy for ITP and presence of a post-poliomyelitis asymmetry.
    Spencer RP, Mittal P.
    Clin Nucl Med; 1998 Jan; 23(1):8-9. PubMed ID: 9442956
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Colloid scintigraphy showing red bone marrow extension in patients with prostatic carcinoma.
    Rudberg U, Udén R, Ahlbäck SO.
    Acta Radiol; 1992 Mar; 33(2):97-102. PubMed ID: 1562417
    [Abstract] [Full Text] [Related]

  • 33. [Diagnostic value of radionuclide visualization of the reticuloendothelial system of macrophages in multiple sclerosis].
    El'chaninov AP, Artiushkin AV, Skoromets AA.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1986 Mar; 86(2):200-3. PubMed ID: 3705822
    [Abstract] [Full Text] [Related]

  • 34. Evaluation of treatment response to enzyme replacement therapy with Velaglucerase alfa in patients with Gaucher disease using whole-body magnetic resonance imaging.
    Laudemann K, Moos L, Mengel E, Lollert A, Hoffmann C, Brixius-Huth M, Wagner D, Düber C, Staatz G.
    Blood Cells Mol Dis; 2016 Mar; 57():35-41. PubMed ID: 26852653
    [Abstract] [Full Text] [Related]

  • 35. Use of technetium-99m sulfur colloid to evaluate changes in reticuloendothelial function in dogs with experimentally induced chronic biliary cirrhosis and portosystemic shunting.
    Koblik PD, Hornof WJ, Yen CK, Fisher PE, Komtebedde J.
    Am J Vet Res; 1995 May; 56(5):688-93. PubMed ID: 7661466
    [Abstract] [Full Text] [Related]

  • 36. Liver-spleen imaging in patients with subacute hepatic necrosis and chronic hepatitis.
    Fischer GJ, Staab EV, Lesesne HR, McCartney WH.
    Clin Nucl Med; 1980 Jan; 5(1):13-8. PubMed ID: 6986221
    [Abstract] [Full Text] [Related]

  • 37. Reconversion of bone marrow in Gaucher disease treated with enzyme therapy documented by MR.
    Allison JW, James CA, Arnold GL, Stine KC, Becton DL, Bell JM.
    Pediatr Radiol; 1998 Apr; 28(4):237-40. PubMed ID: 9545478
    [Abstract] [Full Text] [Related]

  • 38. 99mTc-colloid kits from the view point of the accretion in the bone marrow--with special reference to comparison with 198Au-colloid.
    Ito Y, Muranaka A, Nagai K, Otsuka N, Nishishita S, Uchida M, Kaji T.
    Eur J Nucl Med; 1980 Aug; 5(4):319-26. PubMed ID: 6249599
    [Abstract] [Full Text] [Related]

  • 39. Gaucher's disease type 1: assessment of bone involvement by CT and scintigraphy.
    Hermann G, Goldblatt J, Levy RN, Goldsmith SJ, Desnick RJ, Grabowski GA.
    AJR Am J Roentgenol; 1986 Nov; 147(5):943-8. PubMed ID: 3490167
    [Abstract] [Full Text] [Related]

  • 40. Visualization of residual splenic tissue: a high intensity technique.
    Andrus MS, Johnston GS.
    Clin Nucl Med; 1981 Dec; 6(12):577-8. PubMed ID: 7307407
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.